Artixio

Lifesciences Compliance Services In Argentina

From product concept to market entry and sustainable compliance, we ensure a streamlined regulatory pathway for your Life Sciences product in Argentina.
Artixio serves as the strategic global partner, leveraging expertise to support your product’s journey to market. Our customer-focused, highly experienced team provides you with the right solution for your Life sciences product compliance in Argentina. We provide regulatory intelligence-based, tailored solutions to ensure full compliance with ANMAT. We assure that your product complies with all the safety, quality, and marketing standards in Argentina.

Regulatory Authorities In Argentina

ANMAT

SENASA

Ensure Seamless Regulatory Compliance In Argentina with Artixio:

At Artixio, our dedicated, customer-focused, nimble team focuses on successful product registration and market access in Argentina. We assist in services such as regulatory affairs, product registration, label, artwork, market access, post-market entry, and maintenance services, and many more in the life science sector in Argentina. We help to easily navigate through the robust regulatory framework of ANMAT and SENASA regulations.

Why Trust Artixio with Your Regulatory Journey In Argentina?

End-to-End Support from Product Conceptualization to Launch and Post-Market Support 
ISO 9001:2015, Quality Driven Services Platform  
Flexible, strategic, timely, and quality submissions.
Well networked with regional health authorities and trade associations
Local specialized team with regulatory intelligence-based strategies in Argentina with proven experience of 15-30 years.
Customer-focused, Nimble, Flexible, and Detail-Oriented Team
Direct access to in-house ANMAT regulatory liaisons
Our tech-enabled team with a regulatory intelligence-driven solution ensures sustained compliance.

Our Services

Regulatory Affairs
Product Registration
Market Access
IND (Investigational New Drug)
NDA (New Drug Application)
Regulatory Operations
Technical Writing
Regulatory Strategy
Market Access

Industries We Serve in the European Union

Pharmaceuticals

MedTech

Cosmetics

Nutrition

Biologics

Veterinary

FAQs

1. How to approach the regulatory bodies in Argentina, and what are the modes of communication?
The regulatory bodies in Argentina can be approached through their online portals or emails. Foreign manufacturers must appoint a local representative for their communication with the regulatory authorities in Argentina.
The fees associated with Life sciences product varies from product to product based on their risk level, such as the registration fees for pharmaceuticals range from $1,000 to $4,000, for medical devices, it ranges from $500 to $2,000 and for cosmetics and wellness products it ranges from $200 to $800.
The ANMAT approval time depends upon the product category, such as for generic pharmaceuticals it takes about 6-9 months, for innovative drugs it takes about 12-18 months, and for medical devices it takes about 3-12 months, depending upon the medical device class.
The adverse events in Argentina should be reported through the official pharmacovigilance system of ANMAT on the online portal of ANMAT. These adverse events are reported by the healthcare professionals AND MAH. The adverse report submitted should be in Spanish.
The approval license for marketing in Argentina must be renewed before its 5-year validity period expiring.

Our Global Reach: Serving Life
Sciences Clients Worldwide

India

Singapore

Mexico

Brazil

Vietnam

Malaysia

Argentina

Colombia

Taiwan

China

Europe

Thailand

Indonesia

Philippines

USA

Japan

Qatar

South Korea

Insights from Artixio - Tips & Articles

Pharma Manufacturing Booms in Hidalgo, Mexico

Pharma Manufacturing Booms in

Hildalgo had good pharmaceutical infrastructure and supply chain capabilities, but with no foreign investment...

May 2, 2025
UK Releases Amendment & Guidance on Regulations in 2024 for Medical Devices (Post-market Surveillance Requirements)

UK Releases Amendment &

In January 2025, MHRA UK released guidance on implementation of amendments to Medical Devices...

April 23, 2025
Artixio Announces Grant for Early Stage Medtech Innovators as Part of MedTech InnovateIO Initiative

Artixio Announces Grant for

HYDERABAD, India - March 27, 2024 - Artixio, a leading compliance and commercial consulting...

April 16, 2025